Correlation Between Eli Lilly and Scynexis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Scynexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Scynexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Scynexis, you can compare the effects of market volatilities on Eli Lilly and Scynexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Scynexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Scynexis.

Diversification Opportunities for Eli Lilly and Scynexis

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eli and Scynexis is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Scynexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scynexis and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Scynexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scynexis has no effect on the direction of Eli Lilly i.e., Eli Lilly and Scynexis go up and down completely randomly.

Pair Corralation between Eli Lilly and Scynexis

Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the Scynexis. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 1.17 times less risky than Scynexis. The stock trades about -0.12 of its potential returns per unit of risk. The Scynexis is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  135.00  in Scynexis on August 31, 2024 and sell it today you would earn a total of  2.00  from holding Scynexis or generate 1.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Scynexis

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Scynexis 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Scynexis are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Scynexis is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Eli Lilly and Scynexis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Scynexis

The main advantage of trading using opposite Eli Lilly and Scynexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Scynexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scynexis will offset losses from the drop in Scynexis' long position.
The idea behind Eli Lilly and and Scynexis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules